Recent studies have shown that synthetic peptides can induce antibodies reactive with their cognate sequences in the native proteins (1, 2) . Specific antipeptide antibodies are useful laboratory reagents for confirming de novo proteins from recombinant DNA, exploring biosynthetic pathways and precursors, and probing structural functions of proteins (2) . Synthetic peptide antigens, conveniently available through chemical synthesis, can also be used for producing immunogens and for passive immunoprophylaxis (1) (2) (3) (4) .
A conventional approach to preparing antipeptide antibodies is conjugation of a peptide to a known protein or synthetic polymer carrier to give a macromolecular structure to the antigen carrier (1) (2) (3) . Methods designed to avoid the use of carrier by polymerizing synthetic peptide antigens to give peptide polymers have also been reported recently (4) . Although such materials are effective in producing animal antibodies, these materials are ambiguous in composition and structure; this shortcoming would be particularly disadvantageous were an antipeptide antibody to be used for a human vaccine. It is obviously preferable to design a chemically unambiguous system for producing antibodies in animals and vaccines for humans. To improve on present procedure, an approach, known as the multiple antigen peptide system (MAP), for the preparation of antipeptide antibodies and synthetic vaccines was developed and is described. This approach uses a small peptidyl core matrix bearing radially branching synthetic peptides as dendritic arms (Fig. 1) . One design of a MAP chosen for study consisted with a heptalysine containing eight dendritic arms of peptides 9-16 residues in length. The whole MAP, matrix and peptides, was synthesized by the solid-phase method (5) . After a simple purification scheme, the MAP, which usually has a molecular weight of >10,000, was used directly as the immunizing antigen. This design completely eliminates the conventional step of conjugation of peptide to carrier.
MATERIALS AND METHODS
Synthesis: General Methods. The synthesis of an octabranched matrix core with peptide antigen attached was accomplished manually by a stepwise solid-phase procedure (5) on t-butoxycarbonyl (Boc) ,3Ala-OCH2-Pam resin (6) in which 0.05 mmol of fBAla is present in 0.5 g of resin. The synthesis of the first and every subsequent level of the carrier core was achieved using a 4 M excess of preformed symmetrical anhydride of Na,NE-Boc-Lys(Boc) (0.2, 0.4, 0.8, and 1.6 mmol consecutively) in dimethylformamide (HCONMe2, 12 ml/g resin) followed by a second coupling via dicyclohexylcarbodiimide alone in CH2C12 to give, after deprotection, the octa-branched core matrix containing eight funcAbbreviations: Boc, t-butoxycarbonyl; HCONMe2, dimethylformamide; KLH, keyhole limpet hemocyanin; MAP, multiple antigen peptide system; Boc-Lys (Boc), NN'-Boc2-Lys; TGFa, transforming growth factor type a.
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Proc. Natl. Acad. Sci. USA 85 (1988) tional amino groups (Fig. 1C) . The protecting groups for the synthesis of the peptide antigens were Boc groups for the a-amino termini and benzyl alcohol derivatives for most side-chain amino acids. For all residues except arginine, asparagine, glutamine, and glycine, the first coupling for 1 hr, monitored by a quantitative ninhydrin test (7) was done with the preformed symmetrical anhydride in CH2C12, a second coupling in HCONMe2, and a third (if needed) in Nmethylpyrrolidone at 500C (8) . The coupling of Boc-Asn and Boc-Gln was mediated by the preformed 1-hydroxybenzotriazole ester in HCONMe2. Boc-Gly and Boc-Arg were coupled with water-soluble dicyclohexylcarbodiimide alone to avoid, respectively, the risk of formation of dipeptide and lactam. To eliminate the polycationic amino groups, which give highly charged macromolecules, the peptide chains were capped on their a-amino group by acetylation in 3 mM acetic anhydride in HCONMe2 containing 0.3 mmol of N,Ndimethylaminopyridine at the completion of the MAP. The deprotection process was initiated by removing the dinitrophenyl protecting group of His(Dnp) with 1 M thiophenol in The MAP was lyophilized and purified batchwise by highperformance gel-permeation or ion-exchange chromatography. All purified materials were analyzed and found to contain the predicted amino acid sequences.
Immunization Procedure. Rabbits (New Zealand White, two for each antigen) were immunized by s.c. injection (0.5 ml) of the MAP (1 mg in 1 ml of phosphate buffered saline) in complete Freund's adjuvant (1:1) on day 0 and in incomplete Freund's adjuvant (1:1) on days 21 and 42 and were bled on day 49. Inbred 6-to 8-week-old mice were immunized in the hind footpad with a total of 80 ,g of MAP in complete Freund's adjuvant (1:1) on day 0 and in incomplete Freund's adjuvant at 3-week intervals (total, 2 to 4 times) and bled a week after the last boosting. The antisera were used without purification.
Immunological Assays. An enzyme-linked immunoabsorbent assay (ELISA) was used to test antisera for ability to react with the MAP used for immunization. Peptide antigen (0.5 ,g per well) in carbonate/bicarbonate buffer, pH 9.0 was incubated at 4°C overnight in a 96-well microtiter plate before being washed. Rabbit or mouse antiserum (serially diluted in 0.01 M phosphate-buffered saline) was incubated with the microtiter plate-bound antigen for 2 hr at 20'C and then washed with phosphate-buffered saline. Goat anti-rabbit or anti-mouse IgG horseradish peroxidase conjugate was then added and incubated for an additional hour. After washing with phosphate-buffered saline, the bound conjugate was reacted with chromogen (o-dianisidine dihydrochloride) at 1 mg/ml in 0.01 M phosphate buffer, pH 5.95, for 0.5 hr, and the absorbance of each well was determined with a micro-ELISA reader. 
RESULTS
Concept and Design. The basic idea makes use of a limited sequential propagation of a trifunctional amino acid (or similar homologues) to form a core that serves as a low molecular weight matrix. The trifunctional amino acid, BocLys(Boc), was found to be suitable because both N'-and Ne-amino groups are available as reactive ends. As shown in Fig. 1 , sequential propagation of Boc-Lys(Boc) will generate 2" reactive ends. The first level coupling of Boc-Lys(Boc) will produce two reactive amino ends as a bivalent MAP (Fig.   1A ). The sequential generation of a second, third, and fourth step with Boc-Lys(Boc) will produce MAP containing four Fig. 1D ) reactive amino ends to which peptide antigens are attached. For this study, a design of MAP with an octa-branching core matrix consisting of a heptalysine ( Fig. 1C and 2 ) was synthesized as a prototype. The MAP essentially consists of three structural features (Fig. 2) : (i) a simple amino acid such as glycine or f-alanine bound as a benzyl ester of benzhydrylamide linkage to the solid-phase polymer to initiate the synthesis and serves as internal standard (one amino acid), (ii) an inner core of two to four generating steps of trifunctional amino acids (3-15 amino acids), (iii) a surface layer of acetylated synthetic peptide attached to the inner core matrix (36-288 amino acids for a 6-to 15-residue peptide plus a triglycyl extender). Thus, one major characteristic of the MAP is that the core matrix is small, and the bulk is formed by a high density of uniform peptide antigens layered around the core matrix. This design is in strong contrast to the conventional peptide-carrier conjugate that is comprised of a large protein carrier and a low density of peptide antigens randomly distributed along the support in an unidentified form. In an octa-branched MAP, the peptide antigen accounts for >80% of the total weight of the MAP (Fig. 2) , the MAP having the molecular weight of a small protein. Furthermore, the MAP is oligomeric and contains noncationic peptidyl and isopeptidyl lysine amide linkages on both the N" and NE termini of lysine. Such a design differs markedly from the conventional polylysyl conjugate that is cationic and polymeric in lysyl residues. The short dendritic peptide chains on the MAP are probably mobile and may contribute to the enhanced immunogenicity of the MAP.
Synthesis and Purification. Several points regarding the unusual properties of the MAP should be emphasized to arrive at a high quality product. (i) The synthesis was by the stepwise solid-phase method (5) on a resin synthesized with less than the customary amino acid content because the peptide content increased geometrically with each addition of Boc-Lys(Boc), and the synthesis is difficult if the conventional loading of 0.3-0.8 mmol/g is used (Fig. 3). (ii) HCONMe2 was a more suitable coupling solvent than CH2Cl2 for avoiding potential aggregation of peptides. (iii) The peptide resin should not be dried at any stage of the synthesis because resolvation of dried resin containing MAP is difficult. ( iv) The efficiency of coupling was closely monitored (10) . Synthetic errors such as deletion peptides would be amplified and difficult to correct by conventional purification methods. (v) The cleavage of the MAP from the resin was by an improved acid deprotection method with either HF or trifluoromethanesulfonic acid (9) in dimethyl sulfide to avoid side reactions catalyzed by strong acid.
The MAP was found to have an unusual ability to aggregate, and after cleavage from the resin support, the crude MAP was monomeric and was purified by extensive dialysis in a basic and strongly denaturing condition containing 8 M urea and mercaptoethanol to remove the undesirable aromatic additives of the cleavage reactions such as p-cresol and thiocresol, which tended to strongly adhere to the peptides. In addition, the base treatment under such conditions would also convert any strong acid catalyzed O-acyl rearrangement product of serinyl peptides to the N-acyl peptides and convert any residual level of Met(O) to methionine and His(Dnp) to histidine. The crude MAPs could be further purified by high-performance gel-permeation or ionexchange chromatography. However, in most cases the MAPs could be used for immunization directly, without further purification.
Model Studies. Six model MAPs with synthetic peptides containing [9] [10] [11] [12] [13] [14] [15] [16] residues were injected into animals ( Table 1) . Two MAPs, IG-11 and YP-13, were internal sequences of 11 and 13 residues related respectively to tyrosine protein kinases, p60src (11, 12) and ros (10) . Similarly, peptides FA-14, NP-16, DV-9, antfVS-11 corresponded respectively, to T-cell receptor (13) , circumsporozoite protein of Plasmo- diumfalciparum (14), G. protein (15, 16) , and human transforming growth factor type a (TGFa) (17) were synthesized.
Test of the MAP to Elicit Specific Antisera. The titers of the antisera raised by the MAPs in rabbits and mice were evaluated by ELISA with the corresponding MAPs as substrates. All six MAPs were found to be strong immunogens (Table 1) . Moreover, five of the six MAPs produced antisera that recognized the cognate sequences of the native proteins. The kinetics of responses of two MAPs, IG-11 and YP-13, are shown in Fig. 4 , and an increase of about 10-fold was observed after boostings in either case. In general, good titers of rabbit antibodies were obtained for 10 which is common to the MAP system, we found no observable cross-reactivity between IG-11 and YP-13 (and other MAPs) in ELISA (Fig. 4) . Antibody titers induced by conjugated to KLH by the conventional method of glutaraldehyde were compared with those induced by the IG-11 MAP (Fig. 4A) Fig. 4 . Although IG-11 and YP-13 used the same heptalysinyl MAP core, antisera raised against IG-11 and YP -13 showed no cross-reactivity. Similarly, antibody induced by DV-9 MAPs (Table 1 ) was found to be specific to the at subunit of GTP-binding protein but not cross-reactive with a, subunit, which has considerable sequence homology to ao (19) . Thus, the ao-specific antibody induced by DV-9 MAP was found to be a useful reagent to study the occurrence and distribution of this protein in tissues (19) .
The use of a radially branching system to generate a new polymer has been known in and exclusively confined to classical polymerchemistry. Systems such as star polymers, cauliflower polymers, and star-burst polymers, using multifunctional groups to generate controlled sequence propagation to form new dispersed polymers, are used to produce radial branching of 10 or more levels with >100 reactive ends (20) .
The present system was designed specifically for a biological application. The combined use of a dispersed system with branching oligolysines as a scaffolding for incorporating a high density of some peptide antigen and synthesis by the solid-phase method will greatly simplify the approach of obtaining a chemically defined peptide-antigen carrier system for a biological purpose. Several important issues concerning the present design remain to be resolved, such as the molecular arrangement-i.e., the size, shape, and levels of branching that will affect the antigenicity. Another issue is its flexibility in allowing multiple antigenic peptides to be attached in a MAP, such as the attachment of both T-and B-cell epitopes. Such a design could potentially lead to improved vaccines.
